Related Experiment Video
Updated: Sep 18, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
METTL3-mediated m6A modification regulates D-galactose-induced skin fibroblast senescence through miR-208a-5p
Gaoxiang Huang1,2,3, Sainan Sun1, Mingde Liao4
1School of Basic Medical, Guangxi Medical University, Nanning, Guangxi, China.
Introduction:
As the most abundant epitranscriptomic modification, N6-methyladenosine (m6A) critically influences aging and age-related pathologies. However, its regulatory interplay with microRNAs (miRNAs) in skin aging remains poorly defined.
Methods:
Aging phenotypes were recapitulated using D-galactose (D-gal)-induced senescence models in mouse skin fibroblasts (MSFs) and mice. Interventions included METTL3 overexpression/knockdown, miR-208a-5p mimic/inhibitor transfection, and pharmacological mitophagy induction (GSK). Molecular analyses assessed m⁶A dynamics, gene regulation, and mitochondrial function.
Results:
In D-gal-induced aging models, global RNA hypomethylation and reduced METTL3 expression were observed, while METTL3 overexpression attenuated cellular senescence. Mechanistically, METTL3 depletion elevated miR-208a-5p levels via YTHDF2-mediated m⁶A recognition, establishing epitranscriptional control. This upregulated miR-208a-5p directly targeted the 3'-UTR of OPA1 (optic atrophy type 1), suppressing mitophagic activity. Critically, senescent phenotypes induced by METTL3 knockdown or miR-208a-5p mimicry were reversed by pharmacological mitophagy induction (GSK), confirming mitochondrial homeostasis as the pathway's functional nexus.
Discussion:
These results establish an m6A-dependent METTL3/miR-208a-5p/OPA1 axis that regulates mitophagy and skin aging. Pharmacological rescue of mitophagy highlights this pathway's therapeutic relevance for age-related dermatopathology.
Insights
This study reveals how N6-methyladenosine (m6A) modification, via METTL3, regulates microRNA-208a-5p and OPA1 to control skin cell aging and mitochondrial function.
Area of Science:
- Epitranscriptomics
- Molecular Biology
- Aging Research
Background:
- N6-methyladenosine (m6A) is a key epitranscriptomic mark influencing aging.
- The role of m6A and microRNAs (miRNAs) in skin aging is not fully understood.
Purpose of the Study:
- To elucidate the regulatory network of m6A, miRNAs, and mitochondrial function in skin aging.
- To investigate the METTL3/miR-208a-5p/OPA1 axis in the context of senescence.
Main Methods:
- D-galactose-induced senescence models in mouse skin fibroblasts and mice.
- Manipulation of METTL3 and miR-208a-5p levels.
- Assessment of m6A dynamics, gene expression, and mitochondrial function, including mitophagy.
- Pharmacological intervention with GSK to induce mitophagy.
Main Results:
- Reduced METTL3 and global RNA hypomethylation were observed in aging models.
- METTL3 depletion increased miR-208a-5p, which targets OPA1 and suppresses mitophagy.
- METTL3 overexpression ameliorated senescence, while its knockdown induced it.
- Senescent phenotypes were reversed by pharmacological mitophagy induction.
Conclusions:
- An m6A-dependent pathway involving METTL3, miR-208a-5p, and OPA1 regulates mitophagy and skin aging.
- Restoring mitophagy offers a therapeutic strategy for age-related skin conditions.
More Related Videos
Related Concept Videos
Renewal of Skin Epidermal Stem Cells
TGF - β Signaling Pathway
Abnormal Proliferation
MicroRNAs

